Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review.
Judith E K R HentzenSteven J de JonghPatrick H J HemmerWillemijn Y van der PlasGooitzen M van DamSchelto KruijffPublished in: Journal of surgical oncology (2018)
Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) is a novel intraoperative imaging technique that may improve tumor identification in the future, potentially preventing over- and under-treatment in these patients. This narrative review outlines a chronological overview of MFGS development in patients with PC of colorectal origin.
Keyphrases
- prognostic factors
- minimally invasive
- coronary artery bypass
- single molecule
- surgical site infection
- end stage renal disease
- ejection fraction
- newly diagnosed
- high resolution
- percutaneous coronary intervention
- peritoneal dialysis
- patients undergoing
- atrial fibrillation
- acute coronary syndrome
- photodynamic therapy
- locally advanced